» Articles » PMID: 26287374

P-Glycoprotein Induction Ameliorates Colistin Induced Nephrotoxicity in Cultured Human Proximal Tubular Cells

Overview
Journal PLoS One
Date 2015 Aug 20
PMID 26287374
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of colistin induced nephrotoxicity is poorly understood. Currently there are no effective therapeutic or prophylactic agents available. This study was aimed to determine the mechanism of colistin induced nephrotoxicity and to determine whether P-glycoprotein (P-gp) induction could prevent colistin induced nephrotoxicity. Colistin induced cell toxicity in cultured human proximal tubular cells in both dose and time dependent manner. Colistin provoked ROS in a dose dependent manner as measured by DCF-DA. To investigate apoptosis, caspase 3/7 activity was determined. Caspase 3/7 activity was increased dose dependently (25, 50, 100 μg/ml) at 6 h. Autophagosome formation was assessed by measuring LC3- II/LC3-I ratio. The ratio of LC3-II to LC3- I was increased at 2 h (25 μg/ml). Suppression of autophagosome formation increased colistin induced nephrotoxicity. The expression of P-gp and the cell toxicity was determined in colistin with or without dexamethasone (P-gp inducer) and verapamil (selective P-gp inhibitor). Colistin itself suppressed the expression of P-gp. P-gp expression and activity decreased colistin induced nephrotoxicity with dexamethasone treatment. In addition induced P-gp transporter was shown to improve the efflux effect on colistin treated HK2 cell line, which was demonstrated by calcein-AM fluorescence accumulation assay. The increased activity could be blocked by N-acetylcysteine. In conclusion, colistin induces nephrotoxicity by suppressing P-gp. Induction of P-gp could ameliorate colistin induced nephrotoxicity by decreasing apoptosis.

Citing Articles

Colistin Induces Oxidative Stress and Apoptotic Cell Death through the Activation of the AhR/CYP1A1 Pathway in PC12 Cells.

Xie B, Liu Y, Chen C, Velkov T, Tang S, Shen J Antioxidants (Basel). 2024; 13(7).

PMID: 39061896 PMC: 11273690. DOI: 10.3390/antiox13070827.


Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury .

Varache M, Rizzo S, Sayers E, Newbury L, Mason A, Liao C RSC Pharm. 2024; 1(1):68-79.

PMID: 38646595 PMC: 11024668. DOI: 10.1039/d3pm00014a.


Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity.

Mathew S, Chapla A, Venkatesan P, Eriyat V, Aruldhas B, Prabha R Clin Transl Sci. 2024; 17(3):e13764.

PMID: 38476095 PMC: 10933594. DOI: 10.1111/cts.13764.


Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance.

Balkrishna A, Sharma S, Gohel V, Kumari A, Rawat M, Maity M PLoS One. 2023; 18(11):e0293605.

PMID: 37939153 PMC: 10631690. DOI: 10.1371/journal.pone.0293605.


Silver Nanoparticles Conjugated with Colistin Enhanced the Antimicrobial Activity against Gram-Negative Bacteria.

Muenraya P, Sawatdee S, Srichana T, Atipairin A Molecules. 2022; 27(18).

PMID: 36144516 PMC: 9505607. DOI: 10.3390/molecules27185780.


References
1.
Leslie E, Deeley R, Cole S . Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005; 204(3):216-37. DOI: 10.1016/j.taap.2004.10.012. View

2.
Demeule M, Jodoin J, Beaulieu E, Brossard M, Beliveau R . Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 1999; 442(2-3):208-14. DOI: 10.1016/s0014-5793(98)01663-9. View

3.
Bergen P, Li J, Rayner C, Nation R . Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006; 50(6):1953-8. PMC: 1479097. DOI: 10.1128/AAC.00035-06. View

4.
Li J, Nation R, Turnidge J, Milne R, Coulthard K, Rayner C . Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006; 6(9):589-601. DOI: 10.1016/S1473-3099(06)70580-1. View

5.
Falagas M, Kasiakou S . Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006; 10(1):R27. PMC: 1550802. DOI: 10.1186/cc3995. View